Detail page

Knowledge Web

Person

Johannes Ridinger

Name	Johannes Ridinger
Time	2019- (Wirkungsdaten)
Place	Heidelberg (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Academic degree	Dr. rer. nat. (an der Naturwissenschaftlich-Mathematischen Gesamtfakultät der Ruprecht-Karls-Universität Heidelberg) (2019) M.Sc.
Related	Deutsches Krebsforschungszentrum Zentrum für Kinder- und Jugendmedizin (Heidelberg) Biowissenschaften (Studienfach)
Further information	bis 2018 Doktorand an der Universität Heidelberg Clinical Cooperation Unit Pediatric Oncology (G340), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg
Record type	Person
GND-Identifier	1162237341
Record ID	1162237341
Involved in show all First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement ** Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity First fluorescent acetylspermidine deacetylation assay for HDAC10 identifies selective inhibitors with cellular target engagement Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors HDAC10 in neuroblastoma chemoresistance Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines Body fluid derived exosomes as a novel template for clinical diagnostics

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Johannes Ridinger

First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement **

Design, synthesis and biological characterization of histone deacetylase 8 (HDAC8) proteolysis targeting chimeras (PROTACs) with anti-neuroblastoma activity

First fluorescent acetylspermidine deacetylation assay for HDAC10 identifies selective inhibitors with cellular target engagement

Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors

HDAC10 in neuroblastoma chemoresistance

Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance

The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines

Body fluid derived exosomes as a novel template for clinical diagnostics